Current molecular medicine最新文献

筛选
英文 中文
Neuroprotective Potential of Conditioned Medium from Adipose and Liver Mesenchymal Stem Cells in a Rat Model of Global Cerebral Ischemia-Reperfusion Injury. 脂肪和肝间充质干细胞条件培养基在全脑缺血再灌注损伤大鼠模型中的神经保护作用。
IF 2.2 4区 医学
Current molecular medicine Pub Date : 2025-05-12 DOI: 10.2174/0115665240351634250506164609
Maryam Khombi Shooshtari, Sadegh Moradi Vastegani, Yaghoob Farbood, Alireza Sarkaki, Vahid Bayati, Fereshteh Nejaddehbashi, Seyed Esmaeil Khoshnam, Maryam Farzaneh
{"title":"Neuroprotective Potential of Conditioned Medium from Adipose and Liver Mesenchymal Stem Cells in a Rat Model of Global Cerebral Ischemia-Reperfusion Injury.","authors":"Maryam Khombi Shooshtari, Sadegh Moradi Vastegani, Yaghoob Farbood, Alireza Sarkaki, Vahid Bayati, Fereshteh Nejaddehbashi, Seyed Esmaeil Khoshnam, Maryam Farzaneh","doi":"10.2174/0115665240351634250506164609","DOIUrl":"https://doi.org/10.2174/0115665240351634250506164609","url":null,"abstract":"<p><strong>Background: </strong>Mesenchymal stem cell-derived conditioned medium (MSCCM) contains bioactive factors that provide neuroprotection in cases of cerebral ischemia-reperfusion (IR) injury. This study aimed to compare the therapeutic potential of rat adipose-derived MSC-CM (rAD-MSC-CM) and chicken embryo liver-derived MSC-CM (cLD-MSC-CM) following global cerebral IR injury in male rats.</p><p><strong>Material and methods: </strong>We harvested rAD-MSC-CM from the adipose tissue surrounding the epididymis of Wistar rats and cLD-MSC-CM from the liver tissue of 10- day-old chicken embryos. To induce global cerebral ischemia, we utilized a four-vessel occlusion (4VO) model in rats. After inducing ischemia, the conditioned media were administered via intravenous injection 30 minutes post-reperfusion. We evaluated the cognitive and non-cognitive functions of the animals using standard behavioral tests. Additionally, we assessed blood-brain barrier (BBB) permeability, brain water content (BWC), oxidative-antioxidative status, and conducted histopathological analyses of the hippocampal tissue in the IR rats.</p><p><strong>Results: </strong>Our findings demonstrated that treatment with both rAD-MSC-CM and cLDMSC- CM significantly improved memory function, reduced anxiety- and depressionlike behaviors, and enhanced exploratory activities. These behavioral improvements correlated with decreased BBB permeability and BWC, reduced oxidative stress, and mitigated histopathological changes in the hippocampal tissue.</p><p><strong>Conclusion: </strong>Our findings suggest that both rAD-MSC-CM and cLD-MSC-CM offer protective benefits against IR injury, likely owing to their antioxidant properties.</p>","PeriodicalId":10873,"journal":{"name":"Current molecular medicine","volume":" ","pages":""},"PeriodicalIF":2.2,"publicationDate":"2025-05-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143958535","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
MicroRNA-9-5p Alleviates Oxidative Stress, Inflammation, and Apoptosis in Cerebral Ischemia-reperfusion Injury by Targeting NOX4 In vitro. MicroRNA-9-5p通过靶向NOX4减轻脑缺血再灌注损伤的氧化应激、炎症和凋亡
IF 2.2 4区 医学
Current molecular medicine Pub Date : 2025-05-07 DOI: 10.2174/0115665240337045241210064142
Yuan Huang, Xiaoli Hou, Yixia Wang, Yasen Cao, Yan Zhou, Yu Chen, Hong Cheng
{"title":"MicroRNA-9-5p Alleviates Oxidative Stress, Inflammation, and Apoptosis in Cerebral Ischemia-reperfusion Injury by Targeting NOX4 In vitro.","authors":"Yuan Huang, Xiaoli Hou, Yixia Wang, Yasen Cao, Yan Zhou, Yu Chen, Hong Cheng","doi":"10.2174/0115665240337045241210064142","DOIUrl":"https://doi.org/10.2174/0115665240337045241210064142","url":null,"abstract":"<p><strong>Background: </strong>Prior research has displayed that the dysregulation of miR- 9-5p is related to cerebral ischemia-reperfusion (I/R) injury. However, the underlying neuroprotective mechanism of miR-9-5p in cerebral I/R injury has not been clarified.</p><p><strong>Materials and methods: </strong>The cerebral I/R injury was simulated by oxygen-glucose deprivation/reperfusion (OGD/R) model that was constructed in human SH-SY5Y cells. Changes in reactive oxygen species (ROS) and superoxide dismutase (SOD) levels were detected with the commercial kits. ELISA assay was applied for measuring the expressions of inflammatory cytokines. Western blot was used for testing the protein levels. Cell apoptosis was measured by TUNEL assay.</p><p><strong>Results: </strong>MiR-9-5p expression was dramatically decreased, while NADPH oxidase 4 (NOX4) expression was significantly increased in SH-SY5Y cells under OGD/R operation. MiR-9-5p over-expression dramatically inhibited OGD/R-induced oxidative stress, inflammation, and apoptosis in SH-SY5Y cells. Mechanistically, results from luciferase reporter assay demonstrated that NOX4 was a target of miR-9-5p, and NOX4 over-expression partially reversed the effects of miR-9-5p mimic on oxidative stress, inflammation, and apoptosis in OGD/R SH-SY5Y cells.</p><p><strong>Conclusion: </strong>MiR-9-5p over-expression suppressed oxidative stress, inflammation, and apoptosis in cerebral I/R injury by targeting NOX4, suggesting that miR-9-5p might be a new anti-inflammatory and anti-oxidative modulator in cerebral I/R injury.</p>","PeriodicalId":10873,"journal":{"name":"Current molecular medicine","volume":" ","pages":""},"PeriodicalIF":2.2,"publicationDate":"2025-05-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143972943","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Non-coding RNAs PROX1-AS1 and miR-647: Potential Interaction and Prognostic Value in Gastric Cancer. 非编码rna PROX1-AS1和miR-647在胃癌中的潜在相互作用及其预后价值
IF 2.2 4区 医学
Current molecular medicine Pub Date : 2025-05-05 DOI: 10.2174/0115665240343937250426134726
Irina V Bure, Ekaterina A Vetchinkina, Ekaterina B Kuznetsova, Alexey I Kalinkin, Artem D Molchanov, Alevtina E Kiseleva, Ekaterina A Alekseeva, Neonila V Gorokhovets, Ivan V Rodionov, Marina V Nemtsova
{"title":"Non-coding RNAs PROX1-AS1 and miR-647: Potential Interaction and Prognostic Value in Gastric Cancer.","authors":"Irina V Bure, Ekaterina A Vetchinkina, Ekaterina B Kuznetsova, Alexey I Kalinkin, Artem D Molchanov, Alevtina E Kiseleva, Ekaterina A Alekseeva, Neonila V Gorokhovets, Ivan V Rodionov, Marina V Nemtsova","doi":"10.2174/0115665240343937250426134726","DOIUrl":"https://doi.org/10.2174/0115665240343937250426134726","url":null,"abstract":"<p><strong>Background: </strong>Gastric cancer (GC) remains one of the most common malignancies and the third cause of cancer-related deaths worldwide. Non-coding RNAs (ncRNAs), including microRNAs and long ncRNAs, can contribute to the pathogenesis and progression of GC and therefore could be its potent diagnostic and prognostic biomarkers. The aim of our work was to estimate the expression of PROX1- AS1 (Prospero Homeobox 1 Antisense RNA 1) and miR-647 (microRNA-647) in GC and investigate their potential interaction and clinical significance.</p><p><strong>Methods: </strong>The study included tumor and adjacent non-tumor tissues from 110 GC patients and plasma samples from 65 GC patients; 38 sectional normal gastric tissue samples and 49 plasma samples of healthy donors were included as controls. Expression levels of both ncRNAs were quantified in all samples by using real-time polymerase chain reaction (RT-PCR) and their possible correlations with the clinical and pathological characteristics of patients were analyzed. A potential inverse correlation between PROХ1-AS1 and miR-647 expression was addressed by in vitro experiments in a panel of cancer cell lines.</p><p><strong>Results: </strong>The expression of PROX1-AS1 and miR-647 was not significantly different in tissues of GC patients and sectional normal gastric tissue samples. However, they have demonstrated a negative correlation both in the tumor and the adjacent nontumor tissue of GC patients. PROX1-AS1 expression was significantly decreased in GC tissues, whereas the miR-647 expression was increased. The expression of the ncRNAs was associated with clinical and pathological characteristics of GC patients. The overexpression of miR-647 led to a significant decrease in PROX1-AS1 expression in five cancer cell lines, including the GC cell line SNU-1.</p><p><strong>Conclusion: </strong>We have demonstrated a negative correlation between PROX1-AS1 and miR-647 in both GC tissues and the cancer cell lines. In addition, expression of both ncRNAs was associated with the primary tumor size. Therefore, these ncRNAs might have potential prognostic value.</p>","PeriodicalId":10873,"journal":{"name":"Current molecular medicine","volume":" ","pages":""},"PeriodicalIF":2.2,"publicationDate":"2025-05-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143983999","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Innovative Therapeutic Potential of Herbal Extracts Containing Punicic and Ellagic Acid: Addressing Lower Urinary Tract Disorders. 含有槟榔酸和鞣花酸的草药提取物的创新治疗潜力:解决下尿路疾病。
IF 2.2 4区 医学
Current molecular medicine Pub Date : 2025-05-02 DOI: 10.2174/0115665240378450250410073416
Hrishav Das Purkayastha, Abhishek Bhattacharjee, Ranjit Prasad Swain
{"title":"Innovative Therapeutic Potential of Herbal Extracts Containing Punicic and Ellagic Acid: Addressing Lower Urinary Tract Disorders.","authors":"Hrishav Das Purkayastha, Abhishek Bhattacharjee, Ranjit Prasad Swain","doi":"10.2174/0115665240378450250410073416","DOIUrl":"10.2174/0115665240378450250410073416","url":null,"abstract":"<p><p>This review highlights the new healing frontiers opened by herbal preparations rich in punicic acid, as well as ellagic acid, in the management of Lower Urinary Tract Disorders (LUTD). New data prove that these bioactive compounds possess strong anti-inflammatory, antioxidant, and antibacterial properties, and therefore, can be helpful in treating LUTD symptoms such as urgency, frequency, and dysuria. We conducted a comprehensive pharmacological assessment of punicic and ellagic acids aimed at determining their role in bladder health through modulation of inflammatory processes and both alteration and maintenance of urothelium integrity, in addition to obtaining some background information and chemical properties of these acids. Furthermore, we evaluated the findings of clinical and preclinical studies that demonstrated the ability of these formulations to improve the basic functions of the organs in the urinary system and the quality of life of patients. The review also reflects on the use of herbal extracts in combination with current therapies as a synergistic approach, particularly on the healing effects of such combinations and the need for solid clinical evidence to support such claims. This paper focuses on the concept of how LUTDs can be treated safely and effectively without the help of drugs by integrating modern scientific strategies with traditional approaches, which will thus increase the comprehensiveness of treatment in urological care. Future research should focus on improving how well these compounds are absorbed in the body and gathering long-term safety data, with the goal of incorporating them into treatment guidelines.</p>","PeriodicalId":10873,"journal":{"name":"Current molecular medicine","volume":" ","pages":""},"PeriodicalIF":2.2,"publicationDate":"2025-05-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143995459","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Immunohistochemical Analysis of CYP11B2 (Aldosterone Synthase) and Evaluation of the HISTALDO Classification in Patients with Primary Aldosteronism. 原发性醛固酮增多症患者CYP11B2(醛固酮合成酶)的免疫组化分析及HISTALDO分类的评价。
IF 2.2 4区 医学
Current molecular medicine Pub Date : 2025-05-02 DOI: 10.2174/0115665240378395250416064732
Mustafa Karadepe, Hande Yanar, Hülya Binokay, Şeyda Erdoğan, Gamze Akkus
{"title":"Immunohistochemical Analysis of CYP11B2 (Aldosterone Synthase) and Evaluation of the HISTALDO Classification in Patients with Primary Aldosteronism.","authors":"Mustafa Karadepe, Hande Yanar, Hülya Binokay, Şeyda Erdoğan, Gamze Akkus","doi":"10.2174/0115665240378395250416064732","DOIUrl":"https://doi.org/10.2174/0115665240378395250416064732","url":null,"abstract":"<p><strong>Objective: </strong>Primary Aldosteronism (PA) is the most common cause of secondary hypertension. Immunohistochemical analysis of PA is based on specific monoclonal antibodies targeting CYP11B1 and CYP11B2, which are enzymes responsible for the aldosterone production in the adrenal cortex. The recently proposed HISTALDO classification introduced CYP11B2 immunohistochemistry to define clinically relevant diagnostic categories. We aimed to investigate the relationship between clinical characteristics and immunohistochemistry of CYP11B2 in PA and also evaluate staining in cortisol-producing cells by comparing patients with Cushing's Syndrome (CS). Consecutive patients diagnosed with PA (n=21) and CS (n=20) were included between 2015-2022. All of them underwent unilateral adrenalectomy in our tertiary center.</p><p><strong>Methods: </strong>Following hematoxylin and eosin (H&E) staining of the pathological specimens, all slides were re-evaluated and immunostained for CYP11B2. A semiquantitative H-score was assessed for each patient and compared with staining intensity. Patients with PA were grouped and classified according to the HISTALDO classification.</p><p><strong>Results: </strong>The mean size of adenoma in patients with PA was much smaller compared to patients with CS (p=0.001). An increase in the immunohistochemical H-score of the patients with PA (121.36 ±81.04 vs 73.94±57.70, p=0.045) was observed in comparison to the patients with CS. When comparing the patients with PA according to HISTALDO criteria, the H-score of the patients with Aldosterone Producing Adenoma (APA, n=10) was 136.6±78.86 compared to the non-APA group, which was 86.81±85.3 (n=11, p=0.05). Moreover, mean preoperative aldosterone levels (p=0.06) and aldosterone-to-renin ratio (ARR, p=0.03) were higher in patients with APA compared to non-APA patients. Response to surgical therapy was more favorable in patients with APA than the patients with non-APA.</p><p><strong>Conclusion: </strong>CYP11B2 is a key enzyme responsible for the synthesis of aldosterone. CYP11B2 expression, as assessed by immunostaining, was associated with the clinical characteristics, severity of PA, and response to the treatment. Hence, immunohistochemical analysis of CYP11B2 should be incorporated into the routine clinical workup to better localize aldosterone-producing cells.</p>","PeriodicalId":10873,"journal":{"name":"Current molecular medicine","volume":" ","pages":""},"PeriodicalIF":2.2,"publicationDate":"2025-05-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143967870","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Analysis of Cytokine mRNA Expression During Zika Virus Infection In Mesocricetus auratus. 感染寨卡病毒过程中细胞因子mRNA的表达分析。
IF 2.2 4区 医学
Current molecular medicine Pub Date : 2025-04-30 DOI: 10.2174/0115665240344536250319054657
Wailla Rafaela Barroso Mendes, Karla Fabiane Lopes de Melo, Francisco Canindé Ferreira de Luna, Carolina Ramos Dos Santos, Edna Cristina Dos Santos Franco, Arnaldo Jorge Martins Filho, Pedro Fernando da Costa Vasconcelos, Samir Mansour Moraes Casseb
{"title":"Analysis of Cytokine mRNA Expression During Zika Virus Infection In Mesocricetus auratus.","authors":"Wailla Rafaela Barroso Mendes, Karla Fabiane Lopes de Melo, Francisco Canindé Ferreira de Luna, Carolina Ramos Dos Santos, Edna Cristina Dos Santos Franco, Arnaldo Jorge Martins Filho, Pedro Fernando da Costa Vasconcelos, Samir Mansour Moraes Casseb","doi":"10.2174/0115665240344536250319054657","DOIUrl":"https://doi.org/10.2174/0115665240344536250319054657","url":null,"abstract":"<p><strong>Background: </strong>The Orthoflavivirus zikaense (ZIKV), a member of the Flaviviridae family, has been associated with severe neurological issues, particularly microcephaly, due to its ability to infect neural progenitor cells. This study investigates the mRNA expression of cytokines involved in the inflammatory response during ZIKV infection in Mesocricetus auratus. The research aims to understand the immune response to ZIKV in the context of sexual transmission.</p><p><strong>Methods: </strong>The study utilized hamsters of the species Mesocricetus auratus, divided into four groups: three infected with ZIKV and one control group. The animals were euthanized according to ethical guidelines, and renal tissues were collected. Total RNA was extracted and quantified, and both viral load and cytokine mRNA levels were measured using RT-qPCR. The study targeted cytokines such as TNF-A, RIG-I, RANTES, MDA5, IFN-A, and IFN-B. Statistical analysis was performed using Jamovi v 1.6.</p><p><strong>Results: </strong>The study found that the viral load peaked between 3 and 5 days postinfection and then significantly decreased. The expression of cytokine mRNAs showed distinct patterns, with peaks and declines at various time points post-infection. These patterns differed between male and female subgroups. Pearson correlation analysis revealed negative correlations between mRNA expression and days post-infection in most groups.</p><p><strong>Conclusion: </strong>The study concludes that ZIKV infection in hamsters induces a robust inflammatory response in the kidneys, with dynamic cytokine expression profiles that could serve as markers for monitoring infection and related pathologies. Genderspecific immune responses highlight the complexity of ZIKV pathogenesis, suggesting potential therapeutic targets for Zika-related complications.</p>","PeriodicalId":10873,"journal":{"name":"Current molecular medicine","volume":" ","pages":""},"PeriodicalIF":2.2,"publicationDate":"2025-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143984291","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hemolysis Analysis and Hemolysis-related MicroRNA Candidates for Serum/Plasma Samples. 溶血分析和溶血相关的MicroRNA候选血清/血浆样品。
IF 2.2 4区 医学
Current molecular medicine Pub Date : 2025-04-28 DOI: 10.2174/0115665240375969250421020452
Rongxin He, Yuntao Zhou
{"title":"Hemolysis Analysis and Hemolysis-related MicroRNA Candidates for Serum/Plasma Samples.","authors":"Rongxin He, Yuntao Zhou","doi":"10.2174/0115665240375969250421020452","DOIUrl":"https://doi.org/10.2174/0115665240375969250421020452","url":null,"abstract":"<p><p>Hemolysis is a major challenge in the screening and validation of serum or plasma miRNA biomarkers for human diseases. Over the past decade, numerous studies have focused on hemolysis detection at both the pre-analytical and postanalytical stages to minimize bias in miRNA quantification. Both conventional and advanced hemolysis determination methods have played important roles in quality control in hemolysis assessment and risk prediction during the plasma or serum miRNA quantification process. This review discusses the advantages of these methods and provides an interactive summary of prior knowledge on hemolysissensitive miRNAs and their potential applications in disease diagnosis. Furthermore, the review highlights the advancements in machine learning technologies that enhance classifier predictions and hemolysis risk model evaluations, particularly during the post-analytical stage. Finally, it discusses the ongoing development, standardization, and potential applications of these approaches, which will contribute to a more comprehensive and interpretable framework for the discovery and validation of plasma or serum miRNA biomarkers.</p>","PeriodicalId":10873,"journal":{"name":"Current molecular medicine","volume":" ","pages":""},"PeriodicalIF":2.2,"publicationDate":"2025-04-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143976647","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exercise Alleviates Atherosclerosis Through the Modulation of the NLRP3 Inflammasome. 运动通过调节NLRP3炎性体减轻动脉粥样硬化。
IF 2.2 4区 医学
Current molecular medicine Pub Date : 2025-04-25 DOI: 10.2174/0115665240368171250419113225
Xuan Liu, Shujuan Hu, Xianwang Wang, Yuqing Ding
{"title":"Exercise Alleviates Atherosclerosis Through the Modulation of the NLRP3 Inflammasome.","authors":"Xuan Liu, Shujuan Hu, Xianwang Wang, Yuqing Ding","doi":"10.2174/0115665240368171250419113225","DOIUrl":"https://doi.org/10.2174/0115665240368171250419113225","url":null,"abstract":"<p><p>Atherosclerosis (AS) is a chronic inflammatory disease closely associated with endothelial dysfunction and oxidative stress. The NOD-like receptor protein 3 (NLRP3) inflammasome, a key regulator of inflammatory responses, can exacerbate the progression of AS when activated. Growing evidence suggests that exercise, as a non-pharmacological intervention, can alleviate the progression of AS by modulating the activity of NLRP3 inflammasome. This review discusses how exercise influences the development of AS through the regulation of NLRP3 inflammasome and the underlying molecular mechanism. This study introduces the structure and activation mechanisms of NLRP3 inflammasome, as well as its role in AS. And summarizes how exercise can ameliorate endothelial dysfunction, regulate lipid metabolism, and suppress oxidative stress and inflammation by affecting the expression and activity of NLRP3 inflammasome, thereby exerting a beneficial impact on AS. Additionally, we explore the effects of exercise on the downstream inflammatory cytokines of NLRP3 inflammasome and how this regulation could help to slow the progression of AS. These findings underscore the therapeutic relevance of exercise in the prevention and treatment of AS. It provides new insights into the role of exercise interventions in the management of AS and lays a theoretical foundation for the development of innovative treatment strategies for cardiovascular disease. Given that the NLRP3 inflammatome plays an important role in the pathogenesis and treatment of AS, exercise therapy strategies targeting the NLRP3 inflammatome will help promote the development of precision medicine for AS.</p>","PeriodicalId":10873,"journal":{"name":"Current molecular medicine","volume":" ","pages":""},"PeriodicalIF":2.2,"publicationDate":"2025-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143986765","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prognostic Value and Immunological Role of CBX7 in Lung Adenocarcinoma. CBX7在肺腺癌中的预后价值及免疫学作用。
IF 2.2 4区 医学
Current molecular medicine Pub Date : 2025-04-24 DOI: 10.2174/0115665240374044250416021616
Lingzheng Yang, Yutang Huang, Wenlu Mo, Lanxiang Wu, Chunjie Wen
{"title":"Prognostic Value and Immunological Role of CBX7 in Lung Adenocarcinoma.","authors":"Lingzheng Yang, Yutang Huang, Wenlu Mo, Lanxiang Wu, Chunjie Wen","doi":"10.2174/0115665240374044250416021616","DOIUrl":"https://doi.org/10.2174/0115665240374044250416021616","url":null,"abstract":"<p><strong>Background: </strong>Chromobox 7 (CBX7) has been implicated in the progression of various malignant tumors, but its clinical relevance in lung adenocarcinoma (LUAD) remains poorly understood. This study aimed to investigate the expression, prognostic value, biological functions, and immunological role of CBX7 in LUAD.</p><p><strong>Methods: </strong>CBX7 expression in LUAD and adjacent normal tissues was analyzed using The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) datasets. Kaplan-Meier curves and Cox risk regression evaluated prognostic significance. Various algorithms assessed the correlation between CBX7 and immune microenvironment. The expression of CBX7 in LUAD tissues was detected by RT-qPCR, western blotting, and immunohistochemistry. The function of CBX7 in LUAD was further investigated by in vitro and in vivo experiments.</p><p><strong>Results: </strong>CBX7 expression significantly downregulated LUAD, which was associated with aberrant DNA methylation. Decreased CBX7 expression correlated with advanced tumor stage and poor prognosis. Notably, CBX7 is associated with immune cell infiltration and immune checkpoints, highlighting its potential role in guiding immunotherapy. Functional experiments demonstrated that CBX7 overexpression suppressed the malignant phenotype of LUAD cells, while CBX7 knockdown promoted tumor progression.</p><p><strong>Conclusion: </strong>We conducted a systematic analysis of the diagnostic, prognostic, and immunological significance of CBX7 in LUAD, and found that it might serve as a diagnostic marker and therapeutic target in the future.</p>","PeriodicalId":10873,"journal":{"name":"Current molecular medicine","volume":" ","pages":""},"PeriodicalIF":2.2,"publicationDate":"2025-04-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143968031","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ginsenoside Rg1 Attenuates Muscle Atrophy in Hyperglycemic Conditions, Inactivity and Protein Deprivation Models via AKT/mTOR Pathway Activation. 人参皂苷Rg1通过激活AKT/mTOR通路减轻高血糖、不活动和蛋白质剥夺模型中的肌肉萎缩。
IF 2.2 4区 医学
Current molecular medicine Pub Date : 2025-04-23 DOI: 10.2174/0115665240355315250414051525
Xu He, Yan Li, Jun Chen, Li Zhang, Yan Huang, Ying Zhou, Jing Li
{"title":"Ginsenoside Rg1 Attenuates Muscle Atrophy in Hyperglycemic Conditions, Inactivity and Protein Deprivation Models via AKT/mTOR Pathway Activation.","authors":"Xu He, Yan Li, Jun Chen, Li Zhang, Yan Huang, Ying Zhou, Jing Li","doi":"10.2174/0115665240355315250414051525","DOIUrl":"https://doi.org/10.2174/0115665240355315250414051525","url":null,"abstract":"<p><strong>Background: </strong>Muscle atrophy, a debilitating condition prevalent in diabetes and extended periods of immobilization, lacks robust therapeutic strategies. This investigation examines ginsenoside Rg1's therapeutic potential in counteracting muscle atrophy under hyperglycemic conditions and in experimental models of immobilization and dietary protein restriction.</p><p><strong>Methods: </strong>C2C12 murine myoblasts were cultured under variable glucose concentrations and treated with or without Rg1. Multiple cellular parameters were evaluated, including cell viability, apoptotic indices, cell cycle distribution, and protein synthesis rates. The activation status of the protein kinase B (AKT)/mammalian target of rapamycin (mTOR) signaling cascade and expression of atrophy-related markers were quantified using qRT-PCR and Western blot analyses. In parallel animal studies, rats were subjected to either immobilization or protein restriction protocols, with or without Rg1 administration. Muscle function, mass, and relevant biomarkers were evaluated.</p><p><strong>Results: </strong>Hyperglycemic conditions significantly compromised C2C12 myoblast viability, triggered apoptotic pathways, and disrupted normal cell cycle progression. Rg1 administration effectively attenuated these detrimental effects through enhanced AKT/mTOR pathway activation, upregulation of Myogenin (MyoG) expression, and suppression of atrophy-associated markers. In the rat models, Rg1 supplementation significantly ameliorated muscle deterioration, maintaining muscle mass, contractile force, and exercise tolerance, while simultaneously modulating atrophy signaling pathways and attenuating inflammatory responses. The protective effects of Rg1 were abrogated after the co-treatment with an AKT inhibitor.</p><p><strong>Conclusion: </strong>Ginsenoside Rg1 exhibits significant protective properties against muscle atrophy under hyperglycemic conditions and in experimental models of immobilization and protein restriction, primarily mediated through activation of the AKT/mTOR signaling pathway. These findings establish Rg1 as a promising therapeutic candidate for the treatment of muscle atrophy.</p>","PeriodicalId":10873,"journal":{"name":"Current molecular medicine","volume":" ","pages":""},"PeriodicalIF":2.2,"publicationDate":"2025-04-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143968696","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信